(Q31005004)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11526908%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

review article

1 reference

title

Single domain camel antibodies: current status (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11526908%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11526908%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

S Muyldermans

series ordinal

1

1 reference

28 June 2017

publication date

1 June 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11526908%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

published in

Journal of Biotechnology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11526908%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11526908%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11526908%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

277-302

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11526908%20AND%20SRC:MED&resulttype=core&format=json

Standard conformations for the canonical structures of immunoglobulins

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

'Phytoantibodies': a general vector for the expression of immunoglobulin domains in transgenic plants.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Use of antibody fragments in immunoaffinity chromatography. Comparison of FV fragments, VH fragments and paralog peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Escherichia coli secretion of an active chimeric antibody fragment.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Kinetic analysis of recombinant antibody-antigen interactions: relation between structural domains and antigen binding

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Assembly of functional antibodies from immunoglobulin heavy and light chains synthesised inE. coli

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Production of functional chimaeric mouse/human antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Strategies for expressing human antibody repertoires in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Generation of antibody activity from immunoglobulin polypeptide chains produced in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

The selection of intracellular antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Structural repertoire of the human VH segments

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Canonical structures for the hypervariable regions of immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Conformations of immunoglobulin hypervariable regions

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

'Camelising' human antibody fragments: NMR studies on VH domains.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Antibody VH domains as small recognition units

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Affinity improvement of single antibody VH domains: residues in all three hypervariable regions affect antigen binding

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Single antibody domains as small recognition units: design and in vitro antigen selection of camelized, human VH domains with improved protein stability

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Selection of high-affinity phage antibodies from phage display libraries

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

A single-domain antibody fragment in complex with RNase A: non-canonical loop structures and nanomolar affinity using two CDR loops

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Canonical antigen-binding loop structures in immunoglobulins: more structures, more canonical classes?

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Recent advances in the large-scale production of antibody fragments using lower eukaryotic microorganisms

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Isolation of antigen specific llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Selection and identification of single domain antibody fragments from camel heavy-chain antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

A comparison of strategies to stabilize immunoglobulin Fv-fragments

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Isolation of high affinity human antibodies directly from large synthetic repertoires.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Naturally occurring antibodies devoid of light chains

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Human antibodies from transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Assembly and secretion of heavy chains that do not associate posttranslationally with immunoglobulin heavy chain-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

"Diabodies": small bivalent and bispecific antibody fragments

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Antibody phage display technology and its applications.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Recombinant antibody fragments

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Continuous cultures of fused cells secreting antibody of predefined specificity

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Therapeutic peptides revisited

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Systematic exploration of the antigen binding activity of synthetic peptides isolated from the variable regions of immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Potent enzyme inhibitors derived from dromedary heavy-chain antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Elbow motion in the immunoglobulins involves a molecular ball-and-socket joint

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Comparative properties of the single chain antibody and Fv derivatives of mAb 4-4-20. Relationship between interdomain interactions and the high affinity for fluorescein ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

By-passing immunization. Human antibodies from V-gene libraries displayed on phage

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Affinity selection of a camelized V(H) domain antibody inhibitor of hepatitis C virus NS3 protease

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Both DNA strands of antibody genes are hypermutation targets

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Conformations of the third hypervariable region in the VH domain of immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Loss of splice consensus signal is responsible for the removal of the entire C(H)1 domain of the functional camel IGG2A heavy-chain antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Camel heavy-chain antibodies: diverse germline V(H)H and specific mechanisms enlarge the antigen-binding repertoire

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

The specific variable domain of camel heavy-chain antibodies is encoded in the germline

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Disrupting the hydrophobic patches at the antibody variable/constant domain interface: improved in vivo folding and physical characterization of an engineered scFv fragment.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

A possible procedure for reducing the immunogenicity of antibody variable domains while preserving their ligand-binding properties

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Anatomy of the antibody molecule

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

X-ray crystallography of antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Design and use of a phage display library. Human antibodies with subnanomolar affinity against a marker of angiogenesis eluted from a two-dimensional gel.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

The power of clonal selection

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

An antibody single-domain phage display library of a native heavy chain variable region: isolation of functional single-domain VH molecules with a unique interface.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Somatic hyperconversion diversifies the single Vh gene of the chicken with a high incidence in the D region

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Rearrangement of the former VL interface in the solution structure of a camelised, single antibody VH domain

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Reshaping human antibodies for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Single domain antibodies: comparison of camel VH and camelised human VH domains

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Intracellular antibodies (intrabodies) for gene therapy of infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Heavy Chain Diseases: Current Findings and Concepts

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Anti-tumor effects of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Redefining the minimal antigen-binding fragment

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Structural classification of CDR-H3 in antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

H3-rules: identification of CDR-H3 structures in antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Bacterial expression of immunoglobulin fragments

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Assembly of a functional immunoglobulin Fv fragment in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

The crystal structure of a llama heavy chain variable domain

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Camelid heavy-chain variable domains provide efficient combining sites to haptens

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Transgenic plants expressing a functional single-chain Fv antibody are specifically protected from virus attack

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

"Peptabody": a new type of high avidity binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Somatic generation of antibody diversity

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Camel single-domain antibody inhibits enzyme by mimicking carbohydrate substrate

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Induction of immune responses and molecular cloning of the heavy chain antibody repertoire of Lama glama

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Selection of antibodies for intracellular function using a two-hybrid in vivo system

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Comparison of llama VH sequences from conventional and heavy chain antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Somatic hypermutation introduces insertions and deletions into immunoglobulin V genes

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Making antibodies by phage display technology

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

1 reference

7 January 2021

The structure of the llama heavy chain constant genes reveals a mechanism for heavy-chain antibody formation

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

Length distribution of CDRH3 in antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0352%2801%2900021-6

7 January 2021

10.1016/S1389-0352(01)00021-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11526908%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference